paradigm peptides retatrutide – Peptide Paradise RETATRUTIDE (RETA) – Research Peptide

This slowing contributes to the appetite suppression that drives weight loss and the postprandial glucose-lowering effect, and it also drives most of the gastrointestinal side effect profile.[1],[2] A 2025 review in the Journal of Clinical Endocrinology & Metabolism summarizes the published evidence: GLP-1 receptor agonists impact gastric, intestinal, and gallbladder motility simultaneously, with effects on gastric fundus relaxation, antral contractility inhibition, increased pyloric tone, and reduced small intestinal motility.[3] The path from this mechanism to constipation is straightforward

It's been a massive game-changer

Indonesia DIABETES DRUGS Market Revenue, By Route Of Administration , 2024 2032 (USD Million) 94 18.5

This condition can stem from genetic factors, selenium shortages, or other underlying issues, resulting in a buildup of reactive oxygen species that damage cells over time

Clinical Obesity Journal